Consun Pharmaceutical Group Ltd 2025 Sustainability Report
Company: Consun Pharmaceutical Group Ltd
Sector: Manufacturing
Country: China
Year: 2025
Type: Sustainability Report
Pages: 60
The report describes the company's 2025 ESG governance, materiality assessment, climate performance and workforce priorities. It reports Scope 1 emissions of 7,132.86 Tonnes CO 2 equivalent, Scope 2 emissions of 23,990.59 Tonnes CO 2 equivalent and first-time Scope 3 emissions of 9,922.57 Tonnes CO 2 equivalent. The company established 2030 intensity-reduction targets using 2023 as the base year and a long-term operational carbon-neutrality target for 2060. The Group had 3,115 employees, experienced six work-related safety accidents but no work-related fatal accidents, and obtained limited assurance from Hong Kong Quality Assurance Agency.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.